BioCentury
ARTICLE | Company News

Sevion Therapeutics, Avidity deal

December 15, 2014 8:00 AM UTC

The companies partnered to use Sevion’s chimerasome technology to deliver nucleic acids. Sevion’s chimerasome pipeline includes preclinical SVN-003, which delivers insulin to the liver. Sevion declin...